Sebastien Tilleux

Sebastien Tilleux currently serves as EMEA Medical Affairs Director at Avalyn Pharma Inc. since April 2024. Previously, Tilleux held several key positions, including Medical Director for Belgium & Luxembourg and Medical Lead for Benelux at Alnylam Pharmaceuticals from July 2018 to October 2023, and Sr Medical Affairs Manager for France & Benelux at Prothena Corporation plc from July 2017 to June 2018. Additional experience includes serving as a Medical Science Liaison in Neurosciences at Novartis and at Grünenthal Group, along with roles at UCB, where Tilleux contributed as Global Safety, Medical Process Lead and Drug Safety Scientist. Tilleux holds a Doctorat in Pharmaceutical and Biomedical Sciences and a Master in Health Sciences from Université catholique de Louvain, along with a Master in Management from Louvain School of Management and a Degree of Pharmacist from the University of Liège.